Diabetes Animal Studies
Reports from College of Pharmacy, Department of Pharmacology advance knowledge in diabetes animal studies
Published in Cardiovascular Week, August 11th, 2008
New investigation results, 'Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats,' are detailed in a study published in Molecular and Cellular Biochemistry. "Angiotensin receptor blockers provide cardiovascular protection in heart failure patients. We have studied the effect of 8 weeks treatment with telmisartan (5 mg kg(-1) day(-1)) on cardiovascular complications associated with streptozotocin (STZ) diabetic rats," researchers in Ahmedabad, India report.
"Wistar rats were made diabetic with STZ (45 mg kg(-1), iv). Various biochemical and cardiac parameters were measured at the end of 8 weeks. STZ produced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2008-08-11)
More Articles from Cardiovascular Week
- American Academy of Neurology
Gene may put women with migraine at increased risk of heart disease and stroke - American Cancer Society
Prostate cancer patients undergoing hormone therapy may experience cognitive effects - American Society of Nephrology
Simple lab test for bone disease linked to risk of death in dialysis patients - BioMed Central
Cholesterol-lowering drug boosts bone repair - JAMA and Archives Journals
Study examines prevalence of hearing loss in the US - Journal of the National Cancer Institute
1/5 of British adult survivors of childhood cancer smoke despite hazards - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
